The future of induction chemotherapy for head and neck squamous cell carcinoma

被引：15
|
作者：
Haigentz, Missak, Jr. [1 ]
Cohen, Ezra E. W. [2 ,3 ]
Wolf, Gregory T. [4 ]
Strojan, Primoz [5 ]
Eisbruch, Avraham [6 ]
Ferlito, Alfio [7 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Oncol, Bronx, NY 10467 USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[3] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA
[4] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA
[5] Inst Oncol, Dept Radiat Oncol, Ljubljana, Slovenia
[6] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[7] Univ Udine, ENT Clin, I-33100 Udine, Italy
来源：
ORAL ONCOLOGY | 2012年 / 48卷 / 11期
关键词：
ADVANCED LARYNGEAL-CANCER; ORGAN PRESERVATION; RANDOMIZED-TRIAL; ORAL-CAVITY; RADIOTHERAPY; CISPLATIN; DOCETAXEL; CHEMORADIOTHERAPY; FLUOROURACIL;
D O I：
10.1016/j.oraloncology.2012.08.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1065 / 1067
页数：3
相关论文
共 50 条
  • [31] When is chemotherapy in head and neck squamous cell carcinoma not indicated?
    Missak Haigentz
    Jan B. Vermorken
    Arlene A. Forastiere
    June Corry
    Jonathan J. Beitler
    Primož Strojan
    Dana M. Hartl
    Juan P. Rodrigo
    Carol R. Bradford
    Alessandra Rinaldo
    Robert P. Takes
    William M. Mendenhall
    Ashok R. Shaha
    Gregory T. Wolf
    Alfio Ferlito
    [J]. European Archives of Oto-Rhino-Laryngology, 2015, 272 : 781 - 787
  • [32] Chemotherapy in the management of squamous-cell carcinoma of the head and neck
    Lamont, Elizabeth B.
    Vokes, Everett E.
    [J]. LANCET ONCOLOGY, 2001, 2 (05): : 261 - 269
  • [33] CHEMOTHERAPY STRATEGIES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    ALSARRAF, M
    [J]. CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1984, 1 (04): : 323 - 355
  • [34] Chemotherapy in locally advanced head and neck squamous cell carcinoma
    Gyawali, Bishal
    Shimokata, Tomoya
    Honda, Kazunori
    Ando, Yuichi
    [J]. CANCER TREATMENT REVIEWS, 2016, 44 : 10 - 16
  • [35] TREATMENT OF SQUAMOUS CELL-CARCINOMA OF HEAD AND NECK BY CHEMOTHERAPY
    JEWELL, WR
    [J]. ONCOLOGY, 1972, 26 (2-3) : 238 - +
  • [36] Induction chemotherapy for squamous cancer of the head and neck
    Kies M.S.
    [J]. Current Oncology Reports, 2007, 9 (2) : 129 - 133
  • [37] Induction chemotherapy for squamous cell head and neck cancer: A neverending story?
    Benasso, Marco
    [J]. ORAL ONCOLOGY, 2013, 49 (08) : 747 - 752
  • [38] Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection
    Le, Xiuning
    Gleber-Netto, Frederico O.
    Rubin, M. Laura
    Qing, Yun
    Du, Robyn
    Kies, Merrill
    Blumenschein, George, Jr.
    Lu, Charles
    Johnson, Faye M.
    Bell, Diana
    Lewis, Jeff
    Zhang, Jiexin
    Feng, Lei
    Wilson, Kaye
    Marcelo-Lewis, Kathrina
    Wang, Jing
    Ginsberg, Lawrence
    Gillison, Maura
    Lee, J. Jack
    Meric-Berstam, Funda
    Mills, Gordon B.
    William, William N., Jr.
    Myers, Jeffrey N.
    Pickering, Curtis R.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2796 - 2806
  • [39] Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck
    Bauman, Jessica
    Langer, Corey
    Quon, Harry
    Algazy, Kenneth
    Lin, Alexander
    Desai, Arati
    Mutale, Faith
    Weiss, Jared
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (04) : 1247 - 1253
  • [40] Induction chemotherapy (CT) with weekly paclitaxel, carboplatin, and cetuximab for squamous cell carcinoma of the head and neck (HN).
    Kies, M. S.
    Garden, A. S.
    Holsinger, C.
    Papadimitrakopoulou, V.
    El-Naggar, A. K.
    Gillaspy, K.
    Lewin, J.
    Lu, C.
    Villalobos, S.
    Glisson, B. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 285S - 285S
12345